iVigee
Ernesto Encarnacion is an accomplished professional with extensive experience in the life sciences sector. Currently serving as an Advisor to the Board at iVigee since April 2023, Ernesto has previously held pivotal roles, including Head of Growth and Strategic Partnerships at LynxCare, and Vice President of AI Real World Evidence at Savana. As the Founder and Managing Director of Balaton Consulting Group, Ernesto provided commercial coaching tailored to scientific and operations leaders. Other significant positions include Chief Commercial Officer at Cliantha Research Limited and various leadership roles at PrimeVigilance Ltd. and APCER Life Sciences. Ernesto holds a Master's degree in Applied Intelligence from Georgetown University and two Bachelor's degrees from the University of Pennsylvania and Dickinson College, showcasing a rich educational background.
This person is not in any teams
This person is not in any offices
iVigee
iVigee is a leading pharmacovigilance services and technology company focused on creating simple, powerful, and elegant drug safety solutions that span the entire drug safety life cycle. As true pioneers in our domain, we combine years of internal operational experience and knowledge with the latest innovative AI technologies to deliver a seamless and advanced, client experience. Our culture fosters collaboration, creativity, and the sharing of knowledge with the broader community in the common pursuit of improving drug and patient safety. Our teams support clients around the world with forward-thinking and progressive pharmacovigilance and data management requirements, which combined with our digital solutions, create the ‘instant pharmacovigilance department’, deployable anywhere, on-demand. Strategic bases in Central Europe and the US East Coast allow us to leverage their inherent regional talent, knowledge, and drive towards the latest in AI advancement and implementation, and channel that into current and future products that embody the soul of iVigee: Simple. Powerful. Elegant.